A previous study indicated that PLGA NPs loaded with doxorubicin and curcumin induced greater antitumor effects against breast cancer as a result of curcumin-mediated inhibition of P-glycoprotein (P-gp)-associated drug exclusion [25]. The gene discussed is PGP; the disease is breast carcinoma.